The Roles of Multiparametric Magnetic Resonance Imaging, PCA3 and Prostate Health Index—Which is the Best Predictor of Prostate Cancer after a Negative Biopsy?

Heidenreich, 2014, EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013, Eur Urol, 65, 124, 10.1016/j.eururo.2013.09.046 Jones, 2006, Saturation technique does not improve cancer detection as an initial prostate biopsy strategy, J Urol, 175, 485, 10.1016/S0022-5347(05)00211-9 Djavan, 2001, Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?, J Urol, 166, 1679 Loeb, 2013, Systematic review of complications of prostate biopsy, Eur Urol, 64, 876, 10.1016/j.eururo.2013.05.049 Gittelman, 2013, PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study, J Urol, 190, 64, 10.1016/j.juro.2013.02.018 Lazzeri, 2012, Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy, J Urol, 188, 1137, 10.1016/j.juro.2012.06.017 Stephan, 2013, Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer, Clin Chem, 59, 280, 10.1373/clinchem.2012.195560 Scattoni, 2013, Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy, J Urol, 190, 496, 10.1016/j.juro.2013.02.3184 Perdonà, 2013, Prostate Health Index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy, Prostate, 73, 227, 10.1002/pros.22561 Sciarra, 2011, Advances in magnetic resonance imaging: how they are changing the management of prostate cancer, Eur Urol, 59, 962, 10.1016/j.eururo.2011.02.034 Puech, 2009, Dynamic contrast-enhanced MRI evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens, Urology, 74, 1094, 10.1016/j.urology.2009.04.102 Hoeks, 2011, Prostate cancer: multiparametric MR imaging for detection, localization, and staging, Radiology, 261, 46, 10.1148/radiol.11091822 Tanimoto, 2007, Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging, J Magn Reson Imaging, 25, 146, 10.1002/jmri.20793 Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y Arumainayagam, 2013, Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard, Radiology, 268, 761, 10.1148/radiol.13120641 Semjonow, 2011, Pre-analytical in-vitro stability of [-2]proPSA in blood and serum, Clin Biochem, 43, 926, 10.1016/j.clinbiochem.2010.04.062 Dickinson, 2011, Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting, Eur Urol, 59, 477, 10.1016/j.eururo.2010.12.009 Futterer, 2007, MR imaging in local staging of prostate cancer, Eur J Radiol, 63, 328, 10.1016/j.ejrad.2007.06.029 Rodríguez-Covarrubias, 2011, Extended sampling at first biopsy improves cancer detection rate: results of a prospective, randomized trial comparing 12 versus 18-core prostate biopsy, J Urol, 185, 2132 De Matteis, 2005, Prostate biopsy: characteristics of the histological sample, Arch Ital Urol Androl, 77, 28 Vickers, 2006, Decision curve analysis: a novel method for evaluating prediction models, Med Decis Making, 26, 565, 10.1177/0272989X06295361 Filella, 2013, PCA3 in the detection and management of early prostate cancer, Tumour Biol, 34, 1337, 10.1007/s13277-013-0739-6 Jansen, 2010, Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection, Eur Urol, 57, 921, 10.1016/j.eururo.2010.02.003 Cirillo, 2008, Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours, Clin Radiol, 63, 871, 10.1016/j.crad.2007.10.020 Sciarra, 2012, Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy, BJU Int, 110, 1661, 10.1111/j.1464-410X.2012.11146.x Puech, 2013, Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy–prospective multicenter study, Radiology, 268, 461, 10.1148/radiol.13121501 Pinto, 2011, Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging, J Urol, 186, 1281, 10.1016/j.juro.2011.05.078 Moore, 2013, Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review, Eur Urol, 63, 125, 10.1016/j.eururo.2012.06.004 Siddiqui, 2013, Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy, Eur Urol, 64, 713, 10.1016/j.eururo.2013.05.059 Roethke, 2014, Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla, Eur Radiol, 24, 344, 10.1007/s00330-013-3017-5